CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF...License Agreement • February 23rd, 2023 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This License Agreement (this “Agreement”) is entered into as of January 31, 2023 (the “Effective Date”), by and between GFB (ABC), LLC, a Delaware limited liability company, or its successor in interest (collectively, “GFB”) and Karuna Therapeutics, Inc. (“Karuna”). Karuna and GFB are each referred to herein by name or as a “Party”, or, collectively, as the “Parties”.
